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Abstract
Lung cancer is currently the leading cause of cancer deaths. Among
various subtypes, the number of patients diagnosed with stage I non-small
cell lung cancer (NSCLC), particularly adenocarcinoma, has been increas-
ing. It is estimated that 30 - 40% of stage I patients will relapse, and 10
- 30% will die due to recurrence, clearly suggesting the presence of a sub-
group that could be benefited by additional therapy. We hypothesize that
current attempts to identify stage I NSCLC subgroup failed due to covari-
ate effects, such as the age at diagnosis and differentiation, which may be
masking the results. In this context, to stratify stage I NSCLC, we propose
CEM-Co, a model-based clustering algorithm that removes/minimizes the
effects of undesirable covariates during the clustering process. We applied
CEM-Co on a gene expression data set composed of 129 subjects diag-
nosed with stage I NSCLC and successfully identified a subgroup with a
significantly different phenotype (poor prognosis), while standard cluster-
ing algorithms failed.
Contact: andrefujita@usp.br
1 Introduction
Lung cancer is the most common malignancy worldwide, with an esti-
mated 228 150 new cases, and 142 670 deaths in 2019 only in the United
States (American Cancer Society). There are two main types of lung
cancer, namely non-small cell lung cancer (NSCLC) and small cell lung
cancer (SCLC), which are approximately 80% and about 10 to 15% of
lung cancers, respectively.
Among the patients diagnosed with stage I NSCLC, it is estimated that
30 - 40% will relapse, and 10 - 30% will die due to recurrence. This data
suggests the presence of at least one subgroup that could be benefited
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Figure 1: Schema to illustrate the covariate effect on the clustering structure. Suppose two popula-
tions of subjects sampled from normal distributions with means (20, 30) and (30, 35), and identity
covariance matrices. Moreover, consider that there is a covariate effect on the clustering centroids,
such as age, as follows: (0.1, 0.1) on the first cluster and (−0.2,−0.05) on the second cluster. In
this case, whether we do not take into account the covariate effect during the clustering process,
we cluster some “red” items together with the “black” items and vice-versa. By considering the
covariate effect, we expect to obtain the clustering structure illustrated in panel B.
by additional therapy, whether appropriately identified. Thus, further
stratification and consequent identification of these individuals become
necessary. We hypothesize that one of the reasons that current attempts
to stratify stage I NSCLC fail is due to covariate effects, such as the age
at diagnosis (and many others), which is widely known to be associated
with this disease. To illustrate this hypothesis, see an example in Figure
1. Suppose there are two groups, i.e., controls and patients. Due to
strong covariates effects, such as age at diagnosis, some individuals of
the control group (red dots) are assigned to the patients’ group (black
dots) and vice-versa (Figure 1A). In this case, the clustering algorithm
separated the items into young and elderly. However, what we wished
to obtain is one group of controls and another of the patients (Figure
1B). Therefore, our major problem consists of removing/minimizing the
effects of undesirable clinicopathological covariates (e.g., age at diagnosis,
gender, adjuvant therapy, and differentiation) that would be masking the
results during stratification of stage I NSCLC.
There are several approaches to tackling the problem of clustering
by minimizing the covariates’ effects. One of the most commons is the
one-step approach (a latent class analysis (LCA) based method), which
removes the effects of the covariates from the probability of each item
to belong to each cluster [2, 8]. The problem is that if the strength of
the associations between latent class indicators and latent classes is not
sufficiently strong, then the parameters of the first-phase LCA model may
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be affected by auxiliary variables and models [1, 13, 16, 18]. To overcome
this problem, the three-step approach uses a mixture model to cluster the
data and logistic regression analysis to infer the associations between the
predicted class membership and covariates [11]. The drawback is that
it considers only categorical items, which makes the three-step approach
inappropriate for gene expression data analysis (which are continuous).
Other approaches basis on the latent profile analysis, which considers the
items as continuous data. However, they assume local independence and,
therefore, a specific covariance matrix structure [3],[19].
Moreover, they model the covariate effect on the probability of each
item belonging to each cluster, but not on the clusters’ centroid, where we
would expect the covariate effect. Therefore, we are not able to obtain the
clustering structure filtered out by the effect of the covariates. Methods
to obtain the clustering structure without the effects of covariates usually
consider the covariates as additional dimensions of the items or remove
the effects of the covariates before the clustering process by carrying out
a linear regression. In both cases, the methods assume that the covariates
equally affect the clusters’ centroids, which may not be true (e.g., age and
gender are associated with cancer in different manners).
In this context, we developed a framework namely CEM-Co, which is
composed of (i) a model-based clustering algorithm that takes into ac-
count the covariates effects (on the centroids and/or covariances), (ii) a
statistical test to identify which covariates are associated with the cluster-
ing structure, and (iii) a Bayesian information criterion (BIC) to estimate
the number of clusters.
2 Methods
Let N , K, and P be the number of items, clusters, and covariates, re-
spectively. Also, let xi be the ith M -dimensional item (i = 1, . . . , N),
and zi = (z1,i, z2,i, . . . , zP,i) be the covariates associated with xi. Then,
our goal is to cluster the N items (x1,x2, . . . ,xN ) into K clusters by
considering the P covariates (z1, z2, . . . , zP ).
2.1 CEM-Co
Similar to the clustering expectation-maximization (CEM) algorithm [4,
5], CEM-Co assumes that each cluster is represented by a normal distri-
bution, and therefore the entire data set can be modeled by a mixture of
normal distributions.
Let µ∗j (j = 1, . . . ,K) be the clusters centroids (means of the normal
distributions) without the covariates’ effects, βj,l be the M -dimensional
coefficient representing the strength of the lth covariate effect (l = 1, . . . , P )
on the jth cluster centroid. Then, we model the “observed” clusters cen-
troids as:
µi,j |zi = µ∗j + βj,1z1,i + βj,2z2,i + . . .+ βj,P zP,i. (1)
Let Li,j be a diagonal M ×M matrix whose the rth diagonal (r =
1, . . . ,M) is σr,j + γ1,r,jz1,i + γ2,r,jz2,i + . . . + γP,r,jzP,i, and Ej be a
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M ×M positive definite matrix. Then, we model the covariance matrix
of the multivariate normal distribution (cluster) as:
Σi,j = Li,jEjLi,j . (2)
Notice that Σi,j is in the form of a Choleski decomposition [10], which
implies in a positive-definite matrix. If there is no covariate effect on the
covariance matrix Σi,j , then σr,j = 1 and γl,r,j = 0 for all l = 1, . . . , P ,
r = 1, . . . ,M , and j = 1, . . . ,K. In other words, Li,j is an identity matrix
and, consequently, the covariance matrix is defined only by Ej .
Let
φ(xi, µi,j ,Σi,j) =
exp(− 1
2
(xi − µi,j)>Σ−1i,j (xi − µi,j))√
det(2piΣi,j)
, (3)
be the density of a multivariate normal distribution, and αj be the
weight associated with the jth cluster (
∑K
j=1
αj = 1). Then we can write
the likelihood function as:
L(θ|x1, . . . ,xN ) =
N∏
i=1
K∑
j=1
αjφ(xi, µi,j ,Σi,j). (4)
where θ = (α, µ∗, β,L,E). Based on Equations 1, 2, 3, and 4, we
can simultaneously estimate the parameters (µ∗j , Ej , σr,j , γl,r,j , βj,l, αj)
and carry out the clustering by using an expectation-maximization (EM)
algorithm described in Algorithm 1.
Similar to the CEM algorithm, CEM-Co depends on the initializa-
tion of the parameters in step 2 of Algorithm 1 (αj , µ
∗
j , βj,l,Li,j ,Ej , for
i = 1, . . . , N , j = 1, . . . ,K, and l = 1, . . . , P ). Different initializations
may lead to different likelihood values (EM algorithm usually obtains a
local optimum). Thus, we suggest to run Algorithm 1 several times with
different initialization values and select the one with the highest likelihood.
2.2 Statistical test for the covariate effect
In some empirical data analyses, one may be interested in testing whether
a covariate is statistically associated with the clustering structure.
For example, suppose we want to test whether the lth covariate (zl)
has no effect on the clustering structure. In other words, consider the
following statistical test:
H0 : β1,l = β2,l = . . . = βK,l = 0
versus
H1: At least one βj,l 6= 0 (j = 1, . . . ,K).
To this end, we propose a likelihood ratio test (LRT) [21].
Let L(αj , µ
∗
j , βj,l,Li,j ,Ej |x1, . . . ,xN , β1,l = . . . = βK,l = 0) be the
likelihood function assuming that the lth covariate has no effect on the
jth centroid (the null model), and L(αj , µ
∗
j , βj,l,Li,j ,Ej |x1, . . . ,xN )) be
the likelihood function for the alternative model (Equation 4). Then, we
can define the statistic of the test (D) as:
D = 2{ln(L(θˆ|x1, . . . ,xN ))− ln(L(θˆ0|x1, . . . ,xN ))} (5)
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where θˆ0 are the coefficients obtained by the maximum likelihood estima-
tor under H0 (β1,l = β2,l = . . . = βK,l = 0).
To obtain D, carry out the CEM-Co algorithm with (the alternative
model) and without (the null model) the lth covariate and compare the
two likelihood functions.
The probability distribution of the test statistic D is approximately a
chi-squared distribution with degrees of freedom equal to the number of
parameters of the alternative model minus the number of parameters of
the null model. For example, in our specific test (H0 : β1,l = β2,l = . . . =
βK,l = 0), we have K parameters to be estimated for all αj , KM for all
µ∗j , KMP for all βj,l, KM
2 for all Ej , and 2KM for all Li,j . Thus, the
total number of parameters is K(1 +M(3 + P ) +M2). To test the effect
of a single covariate, we have K(1 + M(2 + P ) + M2) parameters under
H0. Therefore, the number of degrees of freedom for this test is KM .
We may use a similar procedure to test the effect of the lth covariate
(zl,i) on the covariance matrix, i.e.,
H0 : γl,1,1 = γl,1,2 = . . . = γl,1,K = γl,2,1 = . . . = γl,M,K = 0
versus
H1: At least one γl,r,j 6= 0 (j = 1, . . . ,K and r = 1, . . . ,M).
Again, to obtain D, carry out the CEM-Co algorithm with (the alter-
native model) and without (the null model) the lth covariate and compare
the two likelihood functions. The number of degrees of freedom to this case
is also KM (there are KM parameters γl,1,1, . . . , γl,1,K , γl,2,1, . . . , γl,M,K).
To use the chi-squared distribution in the LRT, the likelihood function
must follow the regularity conditions [12]. The proof for these conditions
is straightforward for the tests described in the previous paragraphs, in-
cluding the fact that, under the null hypothesis, the parameters βi,l and
γl,M,K cannot be in the border of the distribution support. Notice that,
under H0, this condition is valid because βi,l and γl,M,K are real numbers
for any i, l,M , and K.
2.3 Estimation of the number of clusters
As described in Algorithm 1, CEM-Co requires the number of clusters (K)
as input. However, in empirical data analysis, we rarely know the number
of clusters a priori; thus, we must estimate it. To estimate the number
of clusters, we propose to use the Bayesian information criterion (BIC).
Let LˆK be the maximized value of the likelihood function (Equation 4)
of the clustering structure obtained by CEM-Co with K clusters, N be
the number of items, and R = K(1 + (3 + P )M + M2) be the number
of parameters estimated by the model. Then, we define the BIC for the
clustering structure obtained by CEM-Co with K clusters as:
BICK = ln(N)R− 2 ln(LˆK). (6)
The estimated number of clusters Kˆ is the one, which minimizes the
BIC statistic (Equation 6).
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2.4 CEM-Co with nonlinear effect
Sometimes the covariates are nonlinearly associated with the clusters’ cen-
troids (e.g., quadratic or sigmoid relationships). In this case, the method
presented in section 2.1 may not be suitable. To model nonlinear rela-
tionships, we extended CEM-Co as follows.
Let fj,l be a function representing the strength of the lth covariate
effect on the jth cluster centroid. Then we can write the “observed”
clusters centroids as :
µi,j = µ
∗
j + fj,1(z1,i) + fj,2(z2,i) + . . .+ fj,P (zP,i). (7)
To model fj,l, we use B-spline [9]. Let S be the number of knots
and B be the polynomial degree of the B-spline, then we represent fj,l
by a matrix Wj,l (with dimensions (N × (S + B))), where the ith row
represents the spline basis of the lth covariate effect on the ith item in the
jth cluster. We define the matrix Wj (N×(P (S+B))) as the combination
of Wj,1,Wj,2, . . . ,Wj,P by columns. Notice that we model the nonlinear
effect only for the centroids, and not for the covariance matrices.
To obtain the CEM-Co algorithm with nonlinear covariates effects,
replace zl by the B-spline basis represented by Wj,l in Algorithm 1. To
statistically test the effect of a single covariate, consider the number of
degrees of freedom as KM(S+B) in the likelihood ratio test (section 2.2).
To estimate the number of clusters (section 2.3), consider the number of
parameters as K(1 +M(3 + P (S +B)) +M2).
3 Simulations
To evaluate the performance of CEM-Co in clustering the items, the power
of the LRT, and the accuracy of the BIC in estimating the number of clus-
ters, we designed three scenarios: (1) the covariates are linearly associated
with the clusters’ centroids, (2) the covariates are associated with the co-
variance matrix, and (3) the covariates are nonlinearly associated with
the clusters’ centroids.
Scenario 1. Covariates with linear effects on the clusters’ centroids.
1. Set the number of clusters (K = 2), the number of dimensions (M =
5), and the number of covariates (P = 5).
2. Set the centroids (means) of the K = 2 clusters to µ∗1 = (0, 0, 0, 0, 0)
and µ∗2 = (0.2, 0.2, 0.2, 0.2, 0.2).
3. Set the effects of the covariates on each cluster (β) as the same as
estimated by CEM-Co in the real data set (Section 4).
4. For each item (i = 1, . . . , N), simulate P = 5 covariates, two from
a normal distribution with zero mean and unit variance (z1,i ∼
N(0, 1), z2,i ∼ N(0, 1)) and three from binomial distributions with
parameters equal to 0.4, 0.25, and 0.15 (z3,i ∼ B(0.4), z4,i ∼ B(0.25),
z5,i ∼ B(0.15)).
5. Simulate N/2 items for each cluster from a multivariate normal dis-
tribution with means equal to µi,j = µ
∗
j+β1,jz1,i+β2,jz2,i+β3,jz3,i+
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β4,jz4,i + β5,jz5,i (for i = 1, . . . , N/2 and j = 1, 2) and a covariance
matrix equals to a (5×5) identity matrix multiplied by 0.03 for each
cluster.
Scenario 2. Covariates with linear effects on the covariance matrices.
1. Set the number of clusters (K = 4), the number of dimensions (M =
2), and the number of covariates (P = 1).
2. Set the centroids (means) of the K = 4 clusters to µ∗1 = (0, 0),
µ∗2 = (0, 1), µ
∗
3 = (1, 0), and µ
∗
4 = (1, 1).
3. Set the effects of the covariate on each cluster to β1 = (0.3, 0.3),
β2 = (−0.3,−0.3), β3 = (0.3,−0.3) and β4 = (−0.3, 0.3).
4. Simulate one covariate for each item (i = 1, . . . , N) from a normal
distribution with unit mean and unit variance (z1,i ∼ N(1, 1)).
5. Let Ej be a (2×2) matrix with 0.1 at the diagonal, σr,j = 1 (for r =
1, 2 and j = 1, 2, 3, 4), γ1,r,j = wj (for r = 1, 2, w1 = 1, w2 = 1, w3 =
1, and w4 = 10), and Li,j be a (2×2) matrix as defined in section 2.1.
Then, simulate N/K items from a multivariate normal distribution
with mean and covariance matrix equal to µi,j = µ
∗
j + βjz1,i and
Σi,j = Li,jEjLi,j , respectively, for each cluster j = 1, . . . ,K.
Scenario 3. Covariates with nonlinear effects on the clustering struc-
tures. To simulate non-linear covariate effects on the clusters centroids,
replace step 5 of scenario 1 by:
1. Let fj,1(z1,i) = βjz1,i + βjz
2
1,i be a quadratic function representing
the strength of the covariate effect on the jth cluster centroid. Then,
simulate N/K items from a multivariate normal distribution with
mean equals to µi,j = µ
∗
j + fj,1(z1,i), and a covariance matrix as
a (2 × 2) identity matrix multiplied by 0.1, for each cluster j =
1, . . . ,K.
For scenario 1, the number of items varied in N = 120, 240, and
360. Notice that we designed this scenario to be similar to the real data
described in section 4. For scenarios 2 and 3, the number of items varied in
N = 200, 300, 400, and 800. For scenario 3, we modeled fj,1 with a cubic
B-spline with four degrees of freedom. We carried out 300 repetitions for
each scenario and each number of items (N).
4 Stage I lung adenocarcinoma
4.1 Stage I NSCLC data set
We collected a set of clinically annotated gene expression data composed of
45 genes and 129 subjects diagnosed with stage I non-small cell lung cancer
(NSCLC) by real-time RT-PCR. We normalized the gene expression levels
relative to the internal housekeeping control 18S gene by using the method
described in [17]. Clinical and pathological characteristics are summarized
in Table 1.
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4.2 Gene expression pre-processing
We re-scaled gene expression data for zero mean and unit variance. Then,
we applied a principal component analysis (PCA) for dimension reduction
and selected (by the elbow method) five principal components (PCs) asso-
ciated with the five largest eigenvalues, which altogether represent 51.87%
of the variance. These five PCs are the representative new dimensions of
the subjects diagnosed with stage I NSCLC. Thus, we have N = 129 in-
dividuals, M = 5 dimensions, and P = 4 covariates (age at diagnosis,
gender, therapy, and differentiation).
5 Results and Discussions
To evaluate the performance of CEM-Co, we compared it against three
other usual approaches, namely:
1. CEM: the application of the standard clustering expectation-maximization
(CEM) algorithm on the original data set, i.e., without taking into
account the covariates;
2. CEM-dimension: the application of the standard CEM algorithm,
but considering the covariates as additional dimensions of the items;
and
3. CEM-partial: the application of the standard CEM algorithm on the
residues of the linear regression model, where the response variable
is the item, and the exploratory variables are the covariates.
We did not compare CEM-Co against the three-step approach because
the clustering structure is the same obtained by CEM (the three-step ap-
proach clusters the data by using CEM and then identifies the association
between the items and covariates).
First, we analyzed the case the covariates are linearly associated with
the centroids. To evaluate how well the algorithms cluster the items, we
calculated the adjusted rand index for each repetition. Since we carried
out all the four algorithms on the same set of items, we present the dif-
ferences between the adjusted rand indices obtained by CEM-Co minus
the one obtained by each of the three alternative methods (Figure 2A).
The greater is this difference; the better is CEM-Co than the alternative
approach. Figure 2A shows that the performance of CEM-Co is better
than all the alternative approaches. Figure 2B shows the frequency the
BIC selected each number of clusters. As expected, the BIC accurately
estimated the correct number of clusters (K = 2) for all examined sample
sizes. Figure 2C shows the ROC curves obtained by testing the covariate
effect. To verify the control of the type I error, we simulated a data set
as described in Section 3 - scenario I, but under the null hypothesis, i.e.,
when there is no covariate effect. Observe that when β = 0 (no covariate
effect), the ROC curve (solid line) should be at the diagonal. Indeed, for
N = 360, the LRT effectively controlled the type I error (the solid line
is at the diagonal). However, for N = 120, 240, the ROC curves (solid
lines) are above the diagonal, i.e., it rejected the null hypothesis more
than the expected by the p-value threshold. Then, for small N , instead
8
of using the LRT, we propose to use a parametric bootstrap procedure.
For N = 120 and p-value thresholds at 0.01, 0.05, and 0.10, the empiri-
cal false-positive rates for the bootstrap-based test (with 1 000 bootstrap
samples) were 0.01, 0.07, and 0.16, respectively, while for the LRT were
0.06, 0.17, and 0.27. Thus, for small N , the type I error is better con-
trolled by the bootstrap procedure than the LRT. Under the alternative
hypothesis, the proportion of rejected null hypothesis (power of the test)
by the LRT increases as the number of items (N) and/or the covariate
effect increases (dashed lines).
We also analyzed the case the covariate affects the covariance. Figure
3A shows that the performance of CEM-Co is better than all the alterna-
tive approaches. Figure 3B shows that the BIC accurately estimated the
correct number of clusters (K = 4) as the sample size increases. Figure
3C shows that, under the null hypothesis, the LRT effectively controlled
the type I error (the solid line is at the diagonal). Under the alternative
hypothesis, the proportion of rejected null hypothesis (power of the test)
by the LRT increases as the number of items (N) and/or the covariate
effect increases (dashed lines).
Besides, we analyzed the case the covariates are nonlinearly (e.g.,
quadratically) associated with the items. Figure 4A shows that the per-
formance of CEM-Co is better than all the alternative approaches. Figure
4B shows that the BIC accurately estimated the correct number of clusters
(K = 4) for all evaluated sample sizes. Figure 4C shows that, under the
null hypothesis, the LRT effectively controlled the type I error (the solid
line is at the diagonal) as the sample size increases. Under the alternative
hypothesis, the proportion of rejected null hypothesis (power of the test)
by the LRT increases as the number of items (N) and/or the covariate
effect increases (dashed lines).
Finally, we applied CEM-Co and the other three alternative methods
on the stage I NSCLC gene expression data. We only analyzed the case
that the effect of covariates may be linearly associated with the centroids.
We did not analyze the effect of covariates on the covariances nor the
nonlinear case because the number of parameters becomes higher than
the number of items/individuals. We considered the age at diagnosis,
gender, adjuvant therapy, and differentiation as covariates.
To estimate the number of clusters, we used the BIC described in
section 2.3. The estimated number of clusters was two for all clustering
algorithms (Figure 5).
After clustering the individuals by using CEM-Co, CEM, CEM-dimension,
and CEM-partial, we verified whether the obtained two clusters present
different phenotypes. One clinically relevant outcome in cancer is survival
time. Then, we analyzed the association of these two clusters with the
survival outcome using a Kaplan-Meier non-parametric curve (Figure 6)
and a multivariate Cox proportional hazards model with age at diagnosis,
gender, adjuvant therapy, and differentiation as covariates (Table 2).
By setting a p-value threshold at 5% in the Kaplan-Meier (KM) anal-
yses, only the CEM algorithm did not stratify the stage I NSCLC data set
into two clusters with different survival outcomes (Figure 6). However,
notice that the KM analysis does not remove the effects of the covariates.
Thus, we also analyzed using the Cox regression model, which considers
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Figure 2: Linear covariate effect on the centroids. (A) Differences between the adjusted rand
indices obtained by CEM-Co and the alternative methods (CEM, CEM-dimension, CEM-partial,
and one-step). The greater is this difference; the better is the performance of CEM-Co than the
alternative method. Error bars represent the 90% confidence intervals. (B) Estimation of the
number of clusters. The bars represent the frequency BIC selected the indicated number of clusters.
For all evaluated number of items (N), BIC selected the number of clusters correctly as two. (C)
ROC curves. The area below the curve represents the power of the statistical test. The solid line
represents the covariate effect under the null hypothesis (β = 0). Dashed lines represent the test
under the alternative hypothesis (β > 0). The power of the LRT increases proportionally to the
number of items (N) and covariate effect strength. For a small number of items (N = 120, 240),
the LRT did not control for the type I error (the solid line is above the diagonal).
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Figure 3: Linear covariate effect on the covariances. (A) Differences between the adjusted rand
indices obtained by CEM-Co and the alternative methods (CEM, CEM-dimension, CEM-partial,
and one-step). The greater is this difference; the better is the performance of CEM-Co than the
alternative methods. Error bars represent the 90% confidence intervals. (B) Estimation of the
number of clusters. The bars represent the frequency BIC selected the indicated number of clusters.
As the number of items increases (N), BIC converges to the correct number of clusters (K = 4).
(C) ROC-like curves. The area below the curve represents the power of the statistical test. The
solid line represents the covariate effect under the null hypothesis (β = 0). Dashed lines represent
the test under the alternative hypothesis (β > 0). The power of the likelihood ratio test increases
proportionally to the number of items (N) and covariate effect strength.
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Figure 4: Nonlinear covariate effect on the centroids. (A) Differences between the adjusted rand in-
dices obtained by CEM-Co and the alternative methods (CEM, CEM-dimension, and CEM-partial).
The greater is this difference; the better is the performance of CEM-Co than the alternative meth-
ods. Error bars represent the 90% confidence intervals. (B) Estimation of the number of clusters.
The bars represent the frequency BIC selected the indicated number of clusters. For all evaluated
number of items (N), BIC selected the number of clusters correctly as four. (C) ROC-like curves.
The area below the curve represents the power of the statistical test. The solid line represents
the covariate effect under the null hypothesis (β = 0). Dashed lines represent the test under the
alternative hypothesis (β > 0). The power of the likelihood ratio test increases proportionally to
the number of items (N) or covariate effect strength.
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Figure 5: Estimation of the number of clusters in stage I NSCLC gene expression data by using the
BIC for CEM-Co. The BIC statistic reaches its minimum value for K = 2. Therefore, the estimated
number of clusters in this data set is Kˆ = 2.
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Figure 6: Kaplan-Meier survival curves constructed based on the clusters obtained by the application
of CEM-Co, CEM, CEM-dimension, and CEM-partial, on the stage I NSCLC gene expression data
set. The p-values were obtained by the log-rank test.
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Figure 7: Covariates effects estimated by CEM-Co on stage I NSCLC. The x and y-axes represent the
M = 5 dimensions of the items (principal components) and the coefficients (β) for each covariate
effect, respectively. Red and black dots represent the patients with good and poor prognoses,
respectively. Error bars represent the 95% confidence intervals (some of them cannot be seen
because they are too small). Except by therapy (p = 0.219), all other covariates are significantly
associated with the clusters’ centroids (age at diagnosis - p = 0.002, gender - p = 0.001, and
differentiation - p = 0.007). Notice that the coefficients (covariates effects) are different between
clusters (between red and black dots) and also among the five dimensions. The coefficients close
to zero for the cluster with worse prognosis (black dots) can be explained probably by the small
cluster size.
the covariates. In this case, only CEM-Co identified a subgroup of stage
I NSCLC with a statistically poorer survival outcome (p < 0.001) (Table
2).
The reason why only CEM-Co was able to identify the poorer subgroup
can be explained by how the covariates affect the clustering structure.
First, except by therapy (p = 0.219), all other covariates signifi-
cantly affect the clusters centroids: age at diagnosis (p = 0.002), gen-
der (p = 0.001), and differentiation (p = 0.007). This result confirms
our hypothesis that covariates indeed affect the stage I NSCLC strati-
fication. Second, the covariates affect both the clusters centroids and
items’ dimensions differently (Figure 7). However, both CEM-dimension
and CEM-partial assume that the covariates affect equally the clusters
centroids.
To verify the robustness of our results, we repeated all analyses by con-
sidering the number of clusters as K = 3 (the second-best choice by BIC
(Figure 5)). In this case, the largest cluster (red curve in Figure 6) was
divided into two clusters (by all clustering methods). The Cox regression
model for the clustering structure obtained by CEM-Co indicated that the
smallest cluster presented a different survival outcome compared to the
other two clusters, while the two largest clusters did not present differ-
ent statistical survival outcomes between them. For the clusters obtained
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by CEM, CEM-dimension, and CEM-partial, the three clusters did not
present statistically different survival outcomes among them. Therefore,
the conclusions obtained for K = 3 were the same at K = 2.
Instead of selecting M = 5 principal components (PCs), we also reana-
lyzed data considering four and six PCs. For four PCs (M = 4, represent-
ing 46.41% of the variance), the results are the same at M = 5. Whether
we consider six PCs (M = 6, representing 55.8% of the variance), CEM-
Co clustered the data set into three groups, i.e., CEM-Co split the largest
group into two groups. The smallest cluster presented a poorer survival
outcome than the other two groups, while we did not observe any sta-
tistical difference between the two largest clusters. Therefore, the results
seem to be robust even for different numbers of PCs.
Here we illustrated the importance of CEM-Co in stratifying a stage
I NSCLC data set by minimizing the effects of age at diagnosis, gender,
adjuvant therapy, and differentiation. However, we imagine that the flexi-
bility of CEM-Co would make it applicable to other areas where clustering
is a source of concern. For example, in large neuroimaging projects, it is
known that the site where the data is collected strongly affects the results.
The EM algorithm has interesting theoretical properties as, for exam-
ple, monotonicity and convergence to a stationary value. The proofs for
our proposal are similar to the one presented in [15]. One just need to
condition on the observed value of zi = (z1,i, z2,i, . . . , zP,i).
One disadvantage of CEM-Co in the present form is that it only can
be applied to data that can be modeled by a mixture of normal distribu-
tions. For example, we cannot apply CEM-Co to data sets represented by
discrete variables. However, we think we can obtain a similar method for
discrete data by using an appropriate probability distribution.
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Algorithm 1: Clustering expectation-maximization with covariates effects
on both the clusters centroids and covariance matrices
Input: the items xi (i = 1, . . . , N), the number of clusters K, and the
covariates zl,i (l = 1, . . . , P ).
Output: the K clusters
1 Let µi,j (Equation 1), Σi,j (Equation 2), αj , and φ(xi, µi,j ,Σi,j)
(Equation 3) be the centroid, the covariance matrix, the weight
associated with the jth normal distribution (j = 1, . . . ,K), and the
density of the multivariate normal distribution, respectively.
2 Randomly initialize the parameters of the K normal distributions, i.e.,
the centroids (µ∗j ), covariances matrices (Ej , σr,j , γl,r,j), covariates
effects (βj,l), and weights for each normal distribution (αj)
(r = 1, . . . ,M).
3 Expectation step. Compute the expected probability for the ith item to
belong to the jth cluster as Pi,j =
αˆjφ(xi,µˆi,j ,Σˆi,j)∑k
l=1
αˆlφ(xi,µˆi,l,Σˆi,l)
.
4 Clustering step. Let C be a (N ×K) matrix where Ci,j = 1 if xi belongs
to the jth cluster, and Ci,j = 0, otherwise. Update C by assigning each
ith item to the jth cluster, which provides the maximum current
expected probability Pi,j .
5 Maximization step. Let dˆi,j = βˆj,1z1,i + βˆj,2z2,i + . . .+ βˆj,P zP,i be the
sum of all covariates effects. Then, compute the maximum likelihood
estimates for µˆ∗j =
∑N
i=1
(xi−dˆi,j)Pˆi,j∑N
i=1
Pˆi,j
,
Eˆj =
∑N
i=1
Pˆi,j(Lˆ
−1
i,j
(xi−µˆ∗j−dˆi,j))(Lˆ−1i,j (xi−µˆ∗j−dˆi,j))>∑N
i=1
Pˆi,j
,
βˆj,l =
∑N
i=1
zl,i(xi−µˆ∗j−dˆi,j+βˆj,lzl,i)Pˆi,j∑N
i=1
z2
l,i
Pˆi,j
, and αˆj =
∑N
i=1
Ci,j
N . To estimate
the maximized value of the likelihood function, find the roots (or zeros)
of the partial derivative of Lˆi,j by using the Newton-Raphson method.
6 Go to step 3 until convergence of the likelihood function (Equation 4).
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Table 1: Clinicopathological characteristics of patients and their tumors. The
data are numbers (%) unless otherwise stated. SD: standard deviation.
Variable Status n
Mean (SD) 66.26 (10.04)
Age at diagnosis (years) ≤ 65 60 (46.51)
65 69 (53.49)
Gender Male 59 (45.74)
Female 74 (54.26)
Yes 18 (13.95)
Therapy No 110 (85.27)
Unknown 1 (0.77)
1 40 (31.00)
Differentiation 2 51 (39.53)
3 38 (29.46)
Dead Yes 48 (37.21)
No 81 (62.79)
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Table 2: Multivariate survival analyses were performed based on the Cox re-
gression model. CI: confidence interval. P-values < 0.05 are in bold.
Method Variables Hazard ratio (95%CI) P-value
Cluster (Red/Black) 0.117 (0.041 - 0.334) <0.001
Age at diagnosis 1.084 (1.048 - 1.121) <0.001
CEM-Co Gender (male/female) 1.231 (0.668 - 2.268) 0.5045
Therapy (yes/no) 2.545 (1.223 - 5.296) 0.013
Differentiation (2/1) 1.348 (0.605 - 3.003) 0.466
Differentiation (3/1) 2.015 (0.853 - 4.762) 0.1101
Cluster (Red/Black) 0.436 (0.181 - 1.052) 0.0646
Age at diagnosis 1.082 (1.045 - 1.120) <0.001
CEM Gender (male/female) 1.220 (0.667 - 2.232) 0.519
Therapy (yes/no) 2.151 (1.049 - 4.410) 0.037
Differentiation (2/1) 2.064 (0.701 - 3.438) 0.278
Differentiation (3/1) 2.064 (0.861 - 4.949) 0.104
Cluster (Red/Black) 0.599 (0.251 - 1.429) 0.248
Age at diagnosis 1.077 (1.041 - 1.115) <0.001
CEM-Dimension Gender (male/female) 0.201 (0.671 - 2.228) 0.511
Therapy (yes/no) 1.378 (0.491 - 3.871) 0.543
Differentiation (2/1) 1.645 (0.722 - 3.750) 0.236
Differentiation (3/1) 2.545 (1.108 - 5.846) 0.028
Cluster (Red/Black) 0.574 (0.290 - 1.137) 0.111
Age at diagnosis 1.076 (1.040 - 1.114) <0.001
CEM-Partial Gender (male/female) 0.796 (0.691 - 2.284) 0.459
Therapy (yes/no) 2.013 (0.975 - 4.156) 0.058
Differentiation (2/1) 1.651 (0.737 - 3.696) 0.223
Differentiation (3/1) 2.538 (1.102 - 5.841) 0.029
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